Roche Pharma India appoints Rajwinder Mehdwan as Country General Manager, effective April 1, 2025. Mehdwan brings over 20 years of experience in the healthcare industry.<\/p>\n
New Delhi, Jan 30 (PTI) Roche Pharma India on Thursday said it has appointed Rajwinder Mehdwan as Country General Manager, effective 1 April 2025.<\/p>\n
Mehdwan will join the CEETRIS (Central Eastern Europe, Turkey, Russia & Indian Subcontinent) region leadership team, reporting to Francois du Toit, Area Head of CEETRIS, Roche Pharmaceuticals, a company statement said.<\/p>\n
She brings over 20 years of experience in the healthcare industry, having held key leadership positions at Roche, and before that at Johnson & Johnson.<\/p>\n
The appointment of Mehdwan “signals our commitment to continue strengthening our partnership with India’s healthcare, address its most critical hurdles and drive sustainable growth for Roche. I firmly believe that her extensive global experience of working with diverse health systems, strategic thinking, business acumen and commitment to Roche’s values makes her an excellent fit for this role,” Francois du Toit said.<\/p>\n
Mehdwan joined Roche in 2010 as Associate Director, Virology and Specialty Care business for Genentech. She held diverse leadership roles – as Portfolio Operations Leader for BioOncology, Portfolio Strategy Director for Denmark, and General Manager for Roche Pharma Norway.<\/p>\n
Roche Pharma India also announced that V Simpson Emmanuel, who has served as General Manager since 2020 will step down due to personal reasons.<\/p>\n","protected":false},"excerpt":{"rendered":"Roche Pharma India appoints Rajwinder Mehdwan as Country General Manager, effective April 1, 2025. Mehdwan brings over 20…\n","protected":false},"author":2,"featured_media":86323,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[44047,4128,337,44046,134,20824],"class_list":["post-86322","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-country-general-manager","tag-healthcare","tag-pharmaceuticals","tag-rajwinder-mehdwan","tag-roche","tag-roche-pharma-india"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/116767831146145963","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/86322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=86322"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/86322\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/86323"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=86322"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=86322"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=86322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}